Preoperative Systemic Therapy for Colorectal Cancer Peritoneal Metastases
Ontology highlight
ABSTRACT: This is an open-label, parallel-group, phase 2 randomized trial which randomizes patients with isolated resectable colorectal cancer peritoneal metastases to receive preoperative systematic therapy followed by CRS+HIPEC and postoperative chemotherapy or upfront CRS+HIPEC followed by postoperative chemotherapy.
DISEASE(S): Peritoneal Neoplasms,Peritoneal Cancer,Neoplasm Metastasis,Chemotherapy Effect,Colorectal Cancer,Colorectal Cancer Metastatic,Colorectal Neoplasms,Hyperthermic Intraperitoneal Chemotherapy,Cytoreductive Surgery,Neoplasms,Peritoneal Metastases
PROVIDER: 2720743 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA